Experienced in IgG4-Related Disease

Dr. Leyla O. Shune

Hematology Oncology | Hematology | Oncology
University Of Kansas Hospital Authority
2650 Shawnee Mission Pkwy, 
Westwood, KS 
Accepting New Patients
Offers Telehealth
17 Years of Experience

Experienced in IgG4-Related Disease
University Of Kansas Hospital Authority
2650 Shawnee Mission Pkwy, 
Westwood, KS 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Leyla Shune is a Hematologist Oncology specialist and a Hematologist in Westwood, Kansas. Dr. Shune has been practicing medicine for over 17 years and is rated as an Experienced provider by MediFind in the treatment of IgG4-Related Disease. Her top areas of expertise are Relapsed Refractory Multiple Myeloma (RRMM), Multiple Myeloma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Shune is currently accepting new patients.

Her clinical research consists of co-authoring 108 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology Oncology
Hematology
Oncology
Licenses
Internal Medicine in KS
Hospital Affiliations
Olathe Medical Center
University Of Kansas Hospital
Languages Spoken
English
Somali
Swahili
Turkish
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Home State Health
  • EPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Louisiana Healthcare Connections
  • HMO
  • MANAGED MEDICAID PLAN
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Sunflower Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 14 Less Insurance Carriers -

Locations

UNIVERSITY OF KANSAS HOSPITAL AUTHORITY
2650 Shawnee Mission Pkwy, Westwood, KS 66205
Call: 913-588-7750
Other Locations
UNIVERSITY OF KANSAS HOSPITAL AUTHORITY
3901 Rainbow Blvd, Kansas City, KS 66160
Call: 913-588-7743

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


7 Clinical Trials

A Randomized Phase 2 Study of CDX-1127 (Varlilumab) in Combination With Nivolumab in Patients With Relapsed or Refractory Aggressive B-cell Lymphomas
A Randomized Phase 2 Study of CDX-1127 (Varlilumab) in Combination With Nivolumab in Patients With Relapsed or Refractory Aggressive B-cell Lymphomas
Enrollment Status: Active_not_recruiting
Publish Date: November 07, 2025
Intervention Type: Biological, Drug
Study Drugs: Nivolumab, Varlilumab
Study Phase: Phase 2
Phase I/II, Open Label, Multicenter Study of Rapcabtagene Autoleucel in Adult Patients With CLL/SLL, 3L+ DLBCL, r/r ALL and 1L HR LBCL
Phase I/II, Open Label, Multicenter Study of Rapcabtagene Autoleucel in Adult Patients With CLL/SLL, 3L+ DLBCL, r/r ALL and 1L HR LBCL
Enrollment Status: Active_not_recruiting
Publish Date: October 28, 2025
Intervention Type: Drug, Biological
Study Drugs: YTB323, Ibrutinib
Study Phase: Phase 1/Phase 2
A Phase 1b/2 Open-Label, Dose Escalation & Expansion Study of Orally Administered Viracta (VRx)-3996 & Valganciclovir in Subjects With Epstein-Barr Virus-Associated Lymphoid Malignancies
A Phase 1b/2 Open-Label, Dose Escalation & Expansion Study of Orally Administered Viracta (VRx)-3996 & Valganciclovir in Subjects With Epstein-Barr Virus-Associated Lymphoid Malignancies
Enrollment Status: Completed
Publish Date: March 20, 2025
Intervention Type: Combination product
Study Drugs: VRx-3996, Valganciclovir
Study Phase: Phase 1/Phase 2
Phase 2 Study of Copanlisib in Combination With Nivolumab in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Primary Mediastinal Large B-Cell Lymphoma
Phase 2 Study of Copanlisib in Combination With Nivolumab in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Primary Mediastinal Large B-Cell Lymphoma
Enrollment Status: Completed
Publish Date: March 03, 2025
Intervention Type: Biological, Drug
Study Drugs: Copanlisib Hydrochloride, Nivolumab
Study Phase: Phase 2
HBO Effects on Blood Count Recovery and Post-transplant Outcomes Following High-dose Therapy and Autologous HSPC Transplantation for Multiple Myeloma
HBO Effects on Blood Count Recovery and Post-transplant Outcomes Following High-dose Therapy and Autologous HSPC Transplantation for Multiple Myeloma
Enrollment Status: Completed
Publish Date: February 07, 2025
Intervention Type: Biological, Other
Study Drug: Hyperbaric Oxygen Therapy
Study Phase: Phase 2
A Randomized Phase II Trial of Myeloablative Versus Non-Myeloablative Consolidation Chemotherapy for Newly Diagnosed Primary CNS B-cell Lymphoma
A Randomized Phase II Trial of Myeloablative Versus Non-Myeloablative Consolidation Chemotherapy for Newly Diagnosed Primary CNS B-cell Lymphoma
Enrollment Status: Active_not_recruiting
Publish Date: August 17, 2021
Intervention Type: Drug, Procedure
Study Drugs: Carmustine, Cytarabine, Etoposide, Thiotepa, Granulocyte Colony-Stimulating Factor
Study Phase: Phase 2
An Exploratory Trial to Estimate the Proportion of Patients With Tumor Cell Contaminated, Flow Positive Leukapheresis Products Collected With and Without Bortezomib as In-vivo Purging Prior to Autologous Stem Cell Harvest for Multiple Myeloma
An Exploratory Trial to Estimate the Proportion of Patients With Tumor Cell Contaminated, Flow Positive Leukapheresis Products Collected With and Without Bortezomib as In-vivo Purging Prior to Autologous Stem Cell Harvest for Multiple Myeloma
Enrollment Status: Completed
Publish Date: June 18, 2021
Intervention Type: Drug
Study Drugs: Bortezomib, Granulocyte Colony-Stimulating Factor (G-CSF), Mozobil
Study Phase: Phase 2
View 6 Less Clinical Trials

105 Total Publications

Predictors of Delayed Responses to Teclistamab in Multiple Myeloma After Initial Non-Response.
Predictors of Delayed Responses to Teclistamab in Multiple Myeloma After Initial Non-Response.
Journal: American journal of hematology
Published: July 30, 2025
View All 105 Publications
Similar Doctors
Experienced in IgG4-Related Disease
Dr. Jacob P. Smeltzer
Hematology Oncology | Hematology | Oncology
Experienced in IgG4-Related Disease
Dr. Jacob P. Smeltzer
Hematology Oncology | Hematology | Oncology

Saint Lukes Physician Group Inc

12330 Metcalf Ave, Suite 580, 
Overland Park, KS 
 (9.3 miles away)
913-317-3230
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Jacob Smeltzer is a Hematologist Oncology specialist and a Hematologist in Overland Park, Kansas. Dr. Smeltzer is rated as a Distinguished provider by MediFind in the treatment of IgG4-Related Disease. His top areas of expertise are Paget Disease of the Breast, Colorectal Cancer, Neuroendocrine Tumor, and Inflammatory Breast Cancer. Dr. Smeltzer is currently accepting new patients.

Experienced in IgG4-Related Disease
Dr. Vinay M. Gupta
Hematology Oncology | Hematology | Oncology
Experienced in IgG4-Related Disease
Dr. Vinay M. Gupta
Hematology Oncology | Hematology | Oncology

Heartland Regional Medical Center

5325 Faraon St, 
Saint Joseph, MO 
 (51.8 miles away)
816-271-3500
Languages Spoken:
English, Hindi
See accepted insurances
Accepting New Patients

Vinay Gupta is a Hematologist Oncology specialist and a Hematologist in Saint Joseph, Missouri. Dr. Gupta is rated as a Distinguished provider by MediFind in the treatment of IgG4-Related Disease. His top areas of expertise are Small Cell Lung Cancer (SCLC), Pleuropulmonary Blastoma, Lung Cancer, Anemia, and Bone Marrow Aspiration. Dr. Gupta is currently accepting new patients.

Experienced in IgG4-Related Disease
Dr. Jeremy R. Flanagan
Hematology Oncology | Hematology | Oncology
Experienced in IgG4-Related Disease
Dr. Jeremy R. Flanagan
Hematology Oncology | Hematology | Oncology

University Of Kansas Hospital Authority

8700 N Green Hiils Rd, 
Kansas City, MO 
 (15.2 miles away)
913-588-1227
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Jeremy Flanagan is a Hematologist Oncology specialist and a Hematologist in Kansas City, Missouri. Dr. Flanagan is rated as a Distinguished provider by MediFind in the treatment of IgG4-Related Disease. His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, Familial Colorectal Cancer, and Colorectal Cancer. Dr. Flanagan is currently accepting new patients.

VIEW MORE IGG4-RELATED DISEASE DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Shune's expertise for a condition
ConditionClose
  • Elite
  • Multiple Myeloma
    Dr. Shune is
    Elite
    . Learn about Multiple Myeloma.
    See more Multiple Myeloma experts
  • Relapsed Refractory Multiple Myeloma (RRMM)
    Dr. Shune is
    Elite
    . Learn about Relapsed Refractory Multiple Myeloma (RRMM).
    See more Relapsed Refractory Multiple Myeloma (RRMM) experts
  • Distinguished
  • Acute Myeloblastic Leukemia with Maturation
    Dr. Shune is
    Distinguished
    . Learn about Acute Myeloblastic Leukemia with Maturation.
    See more Acute Myeloblastic Leukemia with Maturation experts
  • Acute Myeloblastic Leukemia without Maturation
    Dr. Shune is
    Distinguished
    . Learn about Acute Myeloblastic Leukemia without Maturation.
    See more Acute Myeloblastic Leukemia without Maturation experts
  • Acute Myeloid Leukemia (AML)
    Dr. Shune is
    Distinguished
    . Learn about Acute Myeloid Leukemia (AML).
    See more Acute Myeloid Leukemia (AML) experts
  • Bone Marrow Transplant
    Dr. Shune is
    Distinguished
    . Learn about Bone Marrow Transplant.
    See more Bone Marrow Transplant experts
  • Childhood Acute Myeloid Leukemia
    Dr. Shune is
    Distinguished
    . Learn about Childhood Acute Myeloid Leukemia.
    See more Childhood Acute Myeloid Leukemia experts
  • Chronic Graft Versus Host Disease (cGvHD)
    Dr. Shune is
    Distinguished
    . Learn about Chronic Graft Versus Host Disease (cGvHD).
    See more Chronic Graft Versus Host Disease (cGvHD) experts
View All 12 Distinguished Conditions
  • Advanced
  • Acute Lymphoblastic Leukemia (ALL)
    Dr. Shune is
    Advanced
    . Learn about Acute Lymphoblastic Leukemia (ALL).
    See more Acute Lymphoblastic Leukemia (ALL) experts
  • Acute Promyelocytic Leukemia
    Dr. Shune is
    Advanced
    . Learn about Acute Promyelocytic Leukemia.
    See more Acute Promyelocytic Leukemia experts
  • Agranulocytosis
    Dr. Shune is
    Advanced
    . Learn about Agranulocytosis.
    See more Agranulocytosis experts
  • Anaplastic Large Cell Lymphoma
    Dr. Shune is
    Advanced
    . Learn about Anaplastic Large Cell Lymphoma.
    See more Anaplastic Large Cell Lymphoma experts
  • B-Cell Lymphoma
    Dr. Shune is
    Advanced
    . Learn about B-Cell Lymphoma.
    See more B-Cell Lymphoma experts
  • Bone Marrow Aspiration
    Dr. Shune is
    Advanced
    . Learn about Bone Marrow Aspiration.
    See more Bone Marrow Aspiration experts
View All 19 Advanced Conditions
  • Experienced
  • Acquired Amegakaryocytic Thrombocytopenia
    Dr. Shune is
    Experienced
    . Learn about Acquired Amegakaryocytic Thrombocytopenia.
    See more Acquired Amegakaryocytic Thrombocytopenia experts
  • Acute Monoblastic Leukemia (AmoL)
    Dr. Shune is
    Experienced
    . Learn about Acute Monoblastic Leukemia (AmoL).
    See more Acute Monoblastic Leukemia (AmoL) experts
  • Adult Immune Thrombocytopenia
    Dr. Shune is
    Experienced
    . Learn about Adult Immune Thrombocytopenia.
    See more Adult Immune Thrombocytopenia experts
  • Adult T-Cell Leukemia
    Dr. Shune is
    Experienced
    . Learn about Adult T-Cell Leukemia.
    See more Adult T-Cell Leukemia experts
  • Aleukemic Leukemia Cutis (ALC)
    Dr. Shune is
    Experienced
    . Learn about Aleukemic Leukemia Cutis (ALC).
    See more Aleukemic Leukemia Cutis (ALC) experts
  • Anemia
    Dr. Shune is
    Experienced
    . Learn about Anemia.
    See more Anemia experts
View All 44 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved